GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of BPC-157 — 22 things I got wrong before I got it right — 14 comments in the full submission. View in context.
-31
c/bpc157·submitted 2 years ago by u/ismael_chukwu

BPC-157 — 22 things I got wrong before I got it right

Labbranch of 8 comments

Thinking out loud about this: BPC-157 — 22 things I got wrong before I got it right. The three questions, kept separate, because this board runs them together constantly. Identity : is this the sequence I ordered? Answered by mass spectrometry against a theoretical mass. Quantity : how much peptide is in the vial?…

Read the full submission and all 14 comments →

This branch

8 comments, started 2 years ago
u/nils_ferreira3 points·2 years ago

Agreed. Identity is the question here. A short peptide can be synthesised by almost anyone and the sequence is what you are actually buying.

replysharereportpermalink
u/endotoxin_elliemicro1 point·2 years ago

the human evidence is thin and the rodent evidence is not

replysharereportpermalink
u/ismael_chukwuOP1 point·2 years ago

What jurisdiction are you asking about? The answer has changed in several.

replysharereportpermalink
u/yara_antonsen1 point·2 years ago

Went and read the primary rodent papers after arguing about a summary for a week. They are much narrower than the threads suggest.

replysharereportpermalink
u/yara_antonsen1 point·2 years ago

regulatory status varies by jurisdiction and it has moved recently

replysharereportpermalink
u/zaid_eriksen1 point·2 years ago

sequence confirmation is the test worth paying for

replysharereportpermalink
u/mariam_cabrera1 point·2 years ago

Yes — the rodent literature is real and it is rodent literature. The gap to a human claim is enormous and it gets crossed in one sentence here.

replysharereportpermalink
u/arne_ilunga1 point·2 years ago

Push back: "no reported harms" in a literature with almost no human trials is not a safety finding.

replysharereportpermalink

← back to the whole thread

About c/bpc157

BPC-157 as it actually is: a pentadecapeptide with a genuinely interesting rodent tendon-and-gut literature, near-zero controlled human data, a naming and sequence mess in the supply chain, and a regulatory status that changed sharply in several countries.

35kmembers
62submissions
Mar 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/bpc157 rules
  1. Research use only. No human protocols, no injection instructions.
  2. Rodent data must be labelled as rodent data in the body.
  3. Sequence and naming claims need the actual sequence.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.